203 related articles for article (PubMed ID: 31900422)
21. Zoonotic aspects of arenavirus infections.
Charrel RN; de Lamballerie X
Vet Microbiol; 2010 Jan; 140(3-4):213-20. PubMed ID: 19748747
[TBL] [Abstract][Full Text] [Related]
22. Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors.
Brisse ME; Ly H
Front Immunol; 2019; 10():372. PubMed ID: 30918506
[TBL] [Abstract][Full Text] [Related]
23. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
Martinez-Sobrido L; de la Torre JC
Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
[TBL] [Abstract][Full Text] [Related]
24. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses.
Meyer B; Ly H
J Virol; 2016 Apr; 90(8):3810-3818. PubMed ID: 26865707
[TBL] [Abstract][Full Text] [Related]
26. Gairo virus, a novel arenavirus of the widespread Mastomys natalensis: Genetically divergent, but ecologically similar to Lassa and Morogoro viruses.
Gryseels S; Rieger T; Oestereich L; Cuypers B; Borremans B; Makundi R; Leirs H; Günther S; Goüy de Bellocq J
Virology; 2015 Feb; 476():249-256. PubMed ID: 25559385
[TBL] [Abstract][Full Text] [Related]
27. Computational and Functional Analysis of the Virus-Receptor Interface Reveals Host Range Trade-Offs in New World Arenaviruses.
Kerr SA; Jackson EL; Lungu OI; Meyer AG; Demogines A; Ellington AD; Georgiou G; Wilke CO; Sawyer SL
J Virol; 2015 Nov; 89(22):11643-53. PubMed ID: 26355089
[TBL] [Abstract][Full Text] [Related]
28. New World Arenavirus Biology.
Sarute N; Ross SR
Annu Rev Virol; 2017 Sep; 4(1):141-158. PubMed ID: 28645238
[TBL] [Abstract][Full Text] [Related]
29. Reverse genetics approaches to combat pathogenic arenaviruses.
de la Torre JC
Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
[TBL] [Abstract][Full Text] [Related]
30. Novel Insights into Cell Entry of Emerging Human Pathogenic Arenaviruses.
Fedeli C; Moreno H; Kunz S
J Mol Biol; 2018 Jun; 430(13):1839-1852. PubMed ID: 29705070
[TBL] [Abstract][Full Text] [Related]
31. Arenavirus genetic diversity and its biological implications.
Emonet SF; de la Torre JC; Domingo E; Sevilla N
Infect Genet Evol; 2009 Jul; 9(4):417-29. PubMed ID: 19460307
[TBL] [Abstract][Full Text] [Related]
32. Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus.
Caì Y; Yú S; Mazur S; Dong L; Janosko K; Zhang T; Müller MA; Hensley LE; Bavari S; Jahrling PB; Radoshitzky SR; Kuhn JH
J Virol; 2013 Dec; 87(24):13930-5. PubMed ID: 24109228
[TBL] [Abstract][Full Text] [Related]
33. A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.
Kotturi MF; Botten J; Sidney J; Bui HH; Giancola L; Maybeno M; Babin J; Oseroff C; Pasquetto V; Greenbaum JA; Peters B; Ting J; Do D; Vang L; Alexander J; Grey H; Buchmeier MJ; Sette A
PLoS Pathog; 2009 Dec; 5(12):e1000695. PubMed ID: 20019801
[TBL] [Abstract][Full Text] [Related]
34. Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
Leske A; Waßmann I; Schnepel K; Shifflett K; Holzerland J; Bostedt L; Bohn P; Mettenleiter TC; Briggiler AM; Brignone J; Enria D; Cordo SM; Hoenen T; Groseth A
Antiviral Res; 2019 Mar; 163():106-116. PubMed ID: 30668977
[TBL] [Abstract][Full Text] [Related]
35. Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.
Zhang LK; Xin QL; Zhu SL; Wan WW; Wang W; Xiao G
J Virol; 2016 Nov; 90(22):10259-10270. PubMed ID: 27605671
[TBL] [Abstract][Full Text] [Related]
36. Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses.
Koma T; Huang C; Kolokoltsova OA; Brasier AR; Paessler S
J Mol Biol; 2013 Dec; 425(24):4893-903. PubMed ID: 24075870
[TBL] [Abstract][Full Text] [Related]
37. Reverse Genetics Approaches to Control Arenavirus.
Martínez-Sobrido L; Cheng BY; de la Torre JC
Methods Mol Biol; 2016; 1403():313-51. PubMed ID: 27076139
[TBL] [Abstract][Full Text] [Related]
38. Antibody against arenaviruses in humans, southwestern United States.
Milazzo ML; Iralu J; Fulhorst CF; Koster F
Emerg Infect Dis; 2014 Sep; 20(9):1592-3. PubMed ID: 25153356
[No Abstract] [Full Text] [Related]
39. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
Kerber R; Reindl S; Romanowski V; Gómez RM; Ogbaini-Emovon E; Günther S; ter Meulen J
J Clin Virol; 2015 Mar; 64():120-7. PubMed ID: 25549822
[TBL] [Abstract][Full Text] [Related]
40. Past, present, and future of arenavirus taxonomy.
Radoshitzky SR; Bào Y; Buchmeier MJ; Charrel RN; Clawson AN; Clegg CS; DeRisi JL; Emonet S; Gonzalez JP; Kuhn JH; Lukashevich IS; Peters CJ; Romanowski V; Salvato MS; Stenglein MD; de la Torre JC
Arch Virol; 2015 Jul; 160(7):1851-74. PubMed ID: 25935216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
